Loading clinical trials...
Loading clinical trials...
The goal of this pilot randomized controlled trial is to evaluate the trial feasibility and acceptability of mobile chat messaging for reducing alcohol use among patients with chronic liver diseases. ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Hong Kong
Collaborators
NCT07280390 · Cirrhosis, Microplastics, and more
NCT07588854 · Chronic Liver Disease (CLD), Liver Fibrosis
NCT07480057 · Chronic Liver Disease and ACLF
NCT07471542 · Cirrhosis, Chronic Liver Disease, and more
NCT06181409 · Advanced Chronic Liver Disease
Queen Mary Hospital
Hong Kong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions